Reduced Sampling / Reduced Testing

Reduced Sampling / Reduced Testing

Berlin, Germany

Course No 9276


Costs

This conference already took place.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Emerich Grassinger
Aenova Group - Haupt Pharma Wülfing GmbH, Germany
Dr Matthias Heuermann
NRW Centre for Health (LZG.NRW), Germany
Dr Gerald Kindermann
F. Hoffmann-La Roche, Switzerland
Dr Michael Möhlen
Valneva Austria GmbH, Austria
Dr Bernd Renger
Bernd Renger Consulting, Germany
Dr Martin Wesch
Wesch & Buchenroth, Law Office, Germany

Objectives

The aim of this course is to demonstrate the process of the qualification of starting materials (APIs and excipients) and packaging materials (primary and secondary) and to define the prerequisites for implementing a system for reduced sampling and reduced testing for these products. This system has to be in compliance with the actual GMP requirements in Europe and in the US, though. Case Studies will show how to define and optimise sampling and testing procedures and you will discuss further details in a parallel session with 3 workshops

Background

Testing active pharmaceutical ingredients, excipients and packaging materials is one of the main tasks of the quality control units in the pharmaceutical industry. It must be ensured that the necessary tests are conducted on the incoming goods and that the materials are released only after their quality was judged as satisfactory.

According to the revised Chapter 5 – Production – of the EU GMP Guide to come into force on 1 March 2015, the selection, qualification, approval and maintenance of suppliers has to be documented and the level of control has to be proportionate to the potential risks posed by the individual materials. Manufacturers of medicinal products are responsible for testing the starting and packaging materials as described in the marketing authorisation dossier. However, it is explicitly accepted to outsource these testing activities, if the following requirements are fulfilled:

a) Distribution controls (transport, wholesaling, storage and delivery) to ensure the maintenance of the quality characteristics of the starting materials

b) Regularly performed audits at the sites carrying the testing

c) A certificate of analysis signed by a designated person with appropriate qualifications and experience

d) Significant experience in dealing with the starting
material manufacturer (“history of compliance”)

e) Full analyses that are performed regularly by the
medicinal product manufacturer to compare the results with the supplier’s certificate of analysis.

It is the aim of this GMP Education Course to show how these requirements can be put into practice.

Other focus areas of this course are the regulatory requirements for sampling, the design and qualification of sampling areas and the handling of varying specifications in the different pharmacopoeias for identical APIs and excipients used for finished drug products dedicated for the markets in Europe, in the US, and in Japan.
Must different tests be conducted according to EP, USP, and JP, respectively?

The course programme will be completed by a lawyer’s presentation about the legal and contractual liability of suppliers for defect products

Target Group

This GMP Education Course is directed at all those employees from quality control units in the pharmaceutical industry (including heads of quality control and laboratory managers) who are competent or responsible for sampling, testing and release of starting materials (APIs and excipients) and packaging materials (primary and secondary). This course is also of interest to personnel from quality assurance and to those employees from API, excipient or packaging material suppliers who want to inform themselves about the requirements of the pharmaceutical industry on the testing of these materials.

Programme

Regulatory Requirements for Sampling Procedures
API and finished goods sampling
Regulatory requirements
EU GMP Part 1, Chapters 4, 5, 6
EU GMP Part 2, Chapter 7
EU GMP Annex 8
EU GMP Annex 19
Other regulations
US / FDA Requirements
WHO - PIC/S - ISO (former Military Standard)
Supplier qualification and audits
Reduced testing

Design and Qualification of Sampling Areas for
Incoming Goods Products
Sampling area for raw materials, APIs and excipients
Layout and design of premises and equipment
“Cleanroom”-like classification?
What are the appropriate environmental requirements for sampling areas?
How to qualify and maintain sampling areas?
Is a change of pallets/removal of cart boxes required?
Are expectations increasing? - Lessons learned during inspections

Supplier Qualification and Supply Chain Traceability:
an important Prerequisite for Reduced Sampling and Reduced Testing
Prerequisites
Qualification of packaging materials
Qualification of APIs and excipients
Supplier qualification / Supplier audits
Quality Agreements
Specifications / Pharmacopoeial monographs /
Supplier CoA
Complaint Handling

Sampling and Documentation to make the Supplier liable for Defect Products
Legal and Contractual Liability
Definition of a Product Defect
Express Warranty
Admissible Evidence
Insurability

Case Study I: How to Define Inspection Procedures
for Packaging Materials (Primary and Secondary) in
the Incoming Goods Control
Sampling Plans for printed packaging materials, glass containers, plastic containers, etc.
AQL (Acceptable Quality Level)
Tests required according to Ph.Eur. / USP
Options for reduced sampling
Options for reduced testing
Skip lot testing

Case Study II: How to Define and Optimise Sampling and Testing Procedures for APIs and Excipients in the Incoming Goods Control
Sampling Plans for APIs / excipients
Verification of pharmacopoeial procedures
Options for reduced sampling
Options for reducing analytical costs
Use of / NIR / Raman for an efficient control

How to Deal with Divergent Compendial Method
Requirements
ICH QB4 and the Pharmacopoeial Discussion Group
Divergent and conflicting pharmacopoeial requirements
CDER’s MAPP 5310.7 “Acceptability of Standards from Alternative Compendia”
How to proceed in case of missing harmonization?
How to proof equivalence?

Parallel Sessions: Working on specific Tasks

1. Strategies/Prerequisites for Reduced Testing / Reduced Sampling
The aim of this workshop is to evaluate in small discussion groups how the opportunities and requirements
of EU GMP Annex 8 and 21 CFR Part 211 should be
implemented in QA / QC.
Moderator: Dr Bernd Renger

2. Reduced Testing / Reduced Sampling for APIs / Excipients
Participants will discuss and calculate benefits of different measures in small groups. Scenarios of different materials / suppliers / qualification status, use of NIR/RAMAN for identity testing and optimization of the order size to reduce testing effort will be evaluated including their impact on the sampling and testing plans for APIs and excipients.
Moderator: Emerich Grassinger

3. Reduced Testing / Reduced Sampling for Primary and Secondary Packaging Materials
Participants will discuss in small groups scenarios of
different materials / suppliers / qualification status / etc. and their impact on the sampling and testing plans with regard to reduced sampling and reduced testing for packaging.
Moderator: Dr Gerald Kindermann

You will be able to attend 2 of these parallel sessions. Please choose the ones you would like to attend when you register for this Course.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK